22.06.2023 • NewsRöhmSABICpolycarbonate

Röhm Seals Functional Forms Deal with SABIC

German PMMA specialist Röhm has signed a final agreement to acquire SABIC’s Functional form business, which makes high-end polycarbonate film and sheet.

Röhm is stemming the acquisition announced last December with support from its owner, private equity firm Advent International.

At the time, the Darmstadt-based company said the deal, for which financial terms have not been disclosed, was key to its strategy to advance its transparent semi-finished products business into a leading multi-polymer global player.

In future, CEO Michael Pack said, the company’s customers will be able to buy Röhm’s leading transparent PMMA brands Plexiglas and Acrylite as well as SABIC’s Lexan polycarbonate products from one supplier, while profiting from “unparalleled” technical and application expertise.

© Shutterstock/XXL Photo
© Shutterstock/XXL Photo

Adding the Lexan business – acquired by the Saudi group in the 2007 buyout of GE Plastics – not only further strengthens Röhm's leading position in transparent sheets, but also boosts its position in films and transportation, Pack said.

The Functional Form products are used across a wide variety of industries, ranging from building and construction to consumer electronics, medicine and aviation. The Saudi-owned business has some 700 employees and operations in 19 countries.

Author: Dede Williams, Freelance Journalist

Company

Logo:

Röhm GmbH

Deutsche-Telekom-Allee 9
64295 Darmstadt
Germany

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.